NZS Capital’s Medpace MEDP Stock Holding History

NZS Capital’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-70,966	Closed	-$23.7M	–	61
2024 Q3	$23.7M	Buy	70,966 +7,206	+11%	+$2.74M	0.92%	39
2024 Q2	$26.3M	Buy	63,760 +31,753	+99%	+$12.6M	1.08%	33
2024 Q1	$12.9M	Buy	+32,007	New	+$11.3M	0.54%	47

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

NZS Capital's MEDP Position: Q4 2024 in Review

NZS Capital sold out of Medpace (MEDP) in Q4 2024, closing a stake of 70,966 shares — an estimated $23.7M sold.

NZS Capital first reported a position in MEDP in Q1 2024 and held it in 3 quarters. The position peaked at $26.3M in Q2 2024. 592 funds tracked by Wall St. Rank hold MEDP as of Q4 2024.

NZS Capital reported no remaining Medpace position as of Q4 2024 after selling out during the quarter.
NZS Capital sold 70,966 Medpace shares in Q4 2024, an estimated $23.7M.
NZS Capital first reported a position in Medpace in Q1 2024 and held it in 3 quarters.
NZS Capital's Medpace position peaked at $26.3M in Q2 2024.
592 funds tracked by Wall St. Rank held Medpace as of Q4 2024.

Based on NZS Capital's 13F filing for Q4 2024, filed 14 Feb 2025.